Caprock Group’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$369K Sell
74,765
-20,525
-22% -$110K 0.01% 964
2026
Q1
$515K Buy
95,290
+45,550
+92% +$273K 0.01% 739
2025
Q4
$346K Buy
+49,740
New +$327K 0.01% 945

Other funds holding BHC

Caprock Group's BHC Position: Q2 2026 in Review

Caprock Group reduced its Bausch Health (BHC) stake by 22% in Q2 2026, selling an estimated $110K and leaving 74,765 shares worth $369K. The position accounts for 0.01% of the portfolio, ranked #964.

Caprock Group first reported a position in BHC in Q4 2025 and has held it in 3 quarters since. The position peaked at $515K in Q1 2026. 222 funds tracked by Wall St. Rank hold BHC as of Q2 2026.

  • Caprock Group held 74,765 shares of Bausch Health worth $369K as of Q2 2026.
  • Caprock Group sold 20,525 Bausch Health shares in Q2 2026, an estimated $110K.
  • Bausch Health made up 0.01% of Caprock Group's portfolio in Q2 2026, its #964 holding.
  • Caprock Group first reported a position in Bausch Health in Q4 2025 and has held it in 3 quarters since.
  • Caprock Group's Bausch Health position peaked at $515K in Q1 2026.
  • 222 funds tracked by Wall St. Rank held Bausch Health as of Q2 2026.

Based on Caprock Group's 13F filing for Q2 2026, filed 27 Jul 2026.